For Patients With mCRPC, Results With Pluvicto in Real-World Settings Keep Pace With Clinical Trials
Real-world evidence shows Pluvicto matches pivotal trial benefits in PSMA-positive mCRPC, with longer PFS after one ARPI and delayed chemotherapy.
Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.
Learn the impact of nominal, real, and effective interest rates on investors and borrowers, including inflation's role and the cost of compounding.
Discover how inflation targeting helps central banks achieve price stability. Learn the principles, methods, and benefits of this key monetary policy strategy.
Factors Associated with Venous Thromboembolic Disease in a Group of Sub-Saharan Afrcan Population Followed-Up for Cervical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results